Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $2.56 billion. The enterprise value is $5.13 billion.
Important Dates
The next estimated earnings date is Friday, February 28, 2025, before market open.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 309.84 million shares outstanding. The number of shares has increased by 88.69% in one year.
| Current Share Class | 309.84M |
| Shares Outstanding | 309.84M |
| Shares Change (YoY) | +88.69% |
| Shares Change (QoQ) | -2.92% |
| Owned by Insiders (%) | 51.58% |
| Owned by Institutions (%) | 45.87% |
| Float | 148.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.14 |
| PS Ratio | 0.90 |
| Forward PS | 0.89 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.72 |
| P/OCF Ratio | 8.18 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.05, with an EV/FCF ratio of 19.48.
| EV / Earnings | n/a |
| EV / Sales | 1.91 |
| EV / EBITDA | 9.05 |
| EV / EBIT | 15.09 |
| EV / FCF | 19.48 |
Financial Position
The company has a current ratio of 1.38
| Current Ratio | 1.38 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.50 |
| Debt / FCF | 10.05 |
| Interest Coverage | 1.32 |
Financial Efficiency
Return on equity (ROE) is -185.77% and return on invested capital (ROIC) is 7.57%.
| Return on Equity (ROE) | -185.77% |
| Return on Assets (ROA) | 5.94% |
| Return on Capital (ROIC) | 7.57% |
| Revenue Per Employee | $341,455 |
| Profits Per Employee | -$23,497 |
| Employee Count | 7,850 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, AMRX has paid $23.32 million in taxes.
| Income Tax | 23.32M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.39% in the last 52 weeks. The beta is 1.10, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +54.39% |
| 50-Day Moving Average | 8.22 |
| 200-Day Moving Average | 7.57 |
| Relative Strength Index (RSI) | 56.84 |
| Average Volume (20 Days) | 1,077,586 |
Short Selling Information
The latest short interest is 3.30 million, so 1.06% of the outstanding shares have been sold short.
| Short Interest | 3.30M |
| Short Previous Month | 4.67M |
| Short % of Shares Out | 1.06% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, AMRX had revenue of $2.68 billion and -$184.45 million in losses. Loss per share was -$0.63.
| Revenue | 2.68B |
| Gross Profit | 979.05M |
| Operating Income | 339.77M |
| Pretax Income | -157.04M |
| Net Income | -184.45M |
| EBITDA | 566.76M |
| EBIT | 339.77M |
| Loss Per Share | -$0.63 |
Full Income StatementBalance Sheet
The company has $77.26 million in cash and $2.64 billion in debt, giving a net cash position of -$2.57 billion or -$8.29 per share.
| Cash & Cash Equivalents | 77.26M |
| Total Debt | 2.64B |
| Net Cash | -2.57B |
| Net Cash Per Share | -$8.29 |
| Equity (Book Value) | -33.68M |
| Book Value Per Share | -0.30 |
| Working Capital | 418.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $312.84 million and capital expenditures -$49.67 million, giving a free cash flow of $263.18 million.
| Operating Cash Flow | 312.84M |
| Capital Expenditures | -49.67M |
| Free Cash Flow | 263.18M |
| FCF Per Share | $0.85 |
Full Cash Flow StatementMargins
Gross margin is 36.53%, with operating and profit margins of 12.68% and -6.88%.
| Gross Margin | 36.53% |
| Operating Margin | 12.68% |
| Pretax Margin | -4.59% |
| Profit Margin | -6.88% |
| EBITDA Margin | 21.14% |
| EBIT Margin | 12.68% |
| FCF Margin | 9.82% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.69% |
| Shareholder Yield | -88.69% |
| Earnings Yield | -7.21% |
| FCF Yield | 10.28% |
Dividend DetailsAnalyst Forecast
The average price target for AMRX is $10.00, which is 21.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 21.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMRX has an Altman Z-Score of 1.32 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 6 |